Business ❯Pharmaceutical Industry

Corporate Ethics

Medical Ethics Prescription Drugs Fraud Medicare False Claims Act Corporate Ethics Prescription Drugs Medical Practices Regulatory Actions Medical Ethics

Pfizer Settles $59.7M Kickback Allegations Tied to Acquired Migraine Drug

The settlement resolves claims that Biohaven, acquired by Pfizer in 2022, used improper financial incentives to boost prescriptions of Nurtec ODT.